Germacrone: A Multi-targeting Sesquiterpene with Promising Anti-cancer and Chronic Disease Applications

PI3K/AKT/mTOR通路 自噬 疾病 蛋白激酶B 医学 生物信息学 计算生物学 癌症研究 信号转导 化学 生物 细胞凋亡 生物化学 内科学
作者
Navin Kumar Tailor,Ajmer Singh Grewal,Geeta Deswal,Ashwani K. Dhingra
出处
期刊:Anti-cancer Agents in Medicinal Chemistry [Bentham Science Publishers]
卷期号:24 (19): 1396-1406
标识
DOI:10.2174/0118715206312324240805075050
摘要

Background: Germacrone, a naturally occurring active compound found in essential oils extracted from medicinal plants within the Zingiberaceae family, has garnered attention for its potential therapeutic applications. Extensive research has highlighted its multi-targeting capabilities, positioning it as a promising treatment for various chronic diseases, including cancer, cardiovascular conditions, and neurodegenerative disorders like Alzheimer's disease. Objective: This review aims to provide a comprehensive overview of germacrone as a scaffold for developing multi-targeting drugs with therapeutic potential against a range of chronic disorders. The study delves into the molecular mechanisms that underlie the therapeutic effects of germacrone and explores its potential targets, including NF-κB, PI3K/AKT/mTOR, p53, JAK/STAT, caspase, apoptosis, and autophagy induction. Methods: A systematic review of literature databases was conducted to gather relevant studies on germacrone and its therapeutic applications. The molecular mechanisms and potential targets of germacrone were examined to elucidate its multi-targeting capabilities. Results: Germacrone exhibits significant potential in the management of chronic diseases, with demonstrated effects on various cellular pathways. The review highlights its impact on NF-κB, PI3K/AKT/mTOR, p53, JAK/STAT, caspase, apoptosis, and autophagy induction, showcasing its versatility in targeting multiple pathways associated with chronic conditions. Germacrone has emerged as a promising candidate for the treatment of diverse chronic diseases. The understanding of its multi-targeting capabilities, coupled with its natural origin, positions it as a valuable scaffold for developing therapeutics. Conclusion:: The exploration of germacrone as a structural framework for multi-targeting drugs offers a potential avenue to enhance efficacy while minimizing potential side effects. Further research and clinical trials are warranted to validate the therapeutic potential of germacrone in diverse medical contexts.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
量子星尘发布了新的文献求助10
1秒前
星星草完成签到,获得积分10
1秒前
2秒前
勤恳的素阴完成签到 ,获得积分10
2秒前
GYW完成签到,获得积分10
2秒前
胡蝶发布了新的文献求助10
3秒前
ephore应助布鲁斯盖采纳,获得30
3秒前
夜莺发布了新的文献求助10
3秒前
4秒前
4秒前
4秒前
DcQiu科研小白完成签到,获得积分10
5秒前
冰清发布了新的文献求助10
5秒前
柒tt关注了科研通微信公众号
5秒前
6秒前
dandan发布了新的文献求助10
6秒前
科研通AI5应助jjj采纳,获得10
7秒前
zker发布了新的文献求助20
8秒前
莱恩完成签到,获得积分20
8秒前
AHA完成签到,获得积分10
9秒前
10秒前
米子完成签到,获得积分10
10秒前
yujing2025发布了新的文献求助10
10秒前
希望天下0贩的0应助zhan采纳,获得10
10秒前
善学以致用应助猴哥采纳,获得10
11秒前
鄂浩轩发布了新的文献求助10
11秒前
12秒前
红伞伞完成签到 ,获得积分10
12秒前
浮游应助Barium采纳,获得10
12秒前
卧镁铀钳发布了新的文献求助20
12秒前
矮小的尔曼完成签到,获得积分10
12秒前
12秒前
呐呐呐完成签到,获得积分10
13秒前
zhou发布了新的文献求助10
14秒前
14秒前
二胡儿完成签到,获得积分10
14秒前
所所应助YUU采纳,获得10
14秒前
英俊的铭应助dandan采纳,获得10
17秒前
SciGPT应助曲奇饼干采纳,获得10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Einführung in die Rechtsphilosophie und Rechtstheorie der Gegenwart 1500
Cowries - A Guide to the Gastropod Family Cypraeidae 1200
Handbook of Milkfat Fractionation Technology and Application, by Kerry E. Kaylegian and Robert C. Lindsay, AOCS Press, 1995 1000
ESDU TM 218 An example of air data pressure correction with a dependency on engine power settings 400
PRINCIPLES OF BEHAVIORAL ECONOMICS Microeconomics & Human Behavior 400
The Red Peril Explained: Every Man, Woman & Child Affected 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5036407
求助须知:如何正确求助?哪些是违规求助? 4269165
关于积分的说明 13309478
捐赠科研通 4080061
什么是DOI,文献DOI怎么找? 2231912
邀请新用户注册赠送积分活动 1239983
关于科研通互助平台的介绍 1166040